🔗 Share this article Patients Coming Off Weight-Loss Jabs Put On Pounds Far More Rapidly Than Those on Conventional Diets Weight management involves long-term strategies. Fresh analysis suggests that individuals who come off new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle regimens. Findings released in a leading medical journal points out that while overweight individuals often shed about a fifth of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit. "Individuals purchasing these medications should be aware of the potential of fast rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. Such speed of recovery means a return to original mass in about 18 months. Weighing Therapies The study, which reviewed dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods. The team emphasize that people who shed pounds through diet and exercise typically see a more gradual creep back—around 100 grams monthly—post-intervention. The Reason for the Rapid Rebound Doctors suggest the way of the drugs is key to understanding the accelerated regain. The injections copy a body's own chemical called GLP-1, which helps regulate appetite. "Long-term administration of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics expert. "Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating much more probable." A Lifelong Disease? Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes. Many experts contend that, considering the likelihood of relapse, the treatment is often life-long. This view is echoed by pharmaceutical companies, who say that the findings "highlight the persistent nature of excess weight," comparing it to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a intense return of appetite. "It felt as if a trigger activating and you become ravenous," said an individual. This difficulty is compounded if users have not established sustainable lifestyle or habit modifications during treatment. Growing Use Survey data indicate that millions of adults in the UK have tried these injections in the past year, with desire being substantial. Adoption is higher among females than men. The 40s and 50s age group shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than the NHS. Ultimately, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on ongoing behavioural support.
Weight management involves long-term strategies. Fresh analysis suggests that individuals who come off new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle regimens. Findings released in a leading medical journal points out that while overweight individuals often shed about a fifth of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit. "Individuals purchasing these medications should be aware of the potential of fast rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. Such speed of recovery means a return to original mass in about 18 months. Weighing Therapies The study, which reviewed dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods. The team emphasize that people who shed pounds through diet and exercise typically see a more gradual creep back—around 100 grams monthly—post-intervention. The Reason for the Rapid Rebound Doctors suggest the way of the drugs is key to understanding the accelerated regain. The injections copy a body's own chemical called GLP-1, which helps regulate appetite. "Long-term administration of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics expert. "Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating much more probable." A Lifelong Disease? Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes. Many experts contend that, considering the likelihood of relapse, the treatment is often life-long. This view is echoed by pharmaceutical companies, who say that the findings "highlight the persistent nature of excess weight," comparing it to managing conditions like hypertension. Patient Accounts People who have stopped the jabs report a intense return of appetite. "It felt as if a trigger activating and you become ravenous," said an individual. This difficulty is compounded if users have not established sustainable lifestyle or habit modifications during treatment. Growing Use Survey data indicate that millions of adults in the UK have tried these injections in the past year, with desire being substantial. Adoption is higher among females than men. The 40s and 50s age group shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than the NHS. Ultimately, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on ongoing behavioural support.